Family

+

−

Country	kind	publication No.	Filing Date	Type	Sub-Type
CA	C	CA2907484	Mar 13, 2013	Patent	Grant
Type : Patent Sub-Type : Grant
PATENT (SECOND LEVEL)		METHODS AND SYSTEMS FOR ALIGNING REPETITIVE DNA ELEMENTS		Jun 29, 2021
AU	B2	AU2013382195	Mar 13, 2013	Patent	Grant
Type : Patent Sub-Type : Grant
PATENT PROCEEDED BY OPI		Methods and systems for aligning repetitive DNA elements		Sep 19, 2019
WO	A1	WO2014142831	Mar 13, 2013	Patent	Application
Type : Patent Sub-Type : Application
INTERNATIONAL APPLICATION PUBLISHED WITH INTERNATIONAL SEARCH REPORT		METHODS AND SYSTEMS FOR ALIGNING REPETITIVE DNA ELEMENTS		Sep 18, 2014
EP	B1	EP2971069	Mar 13, 2013	Patent	Grant
Type : Patent Sub-Type : Grant
Patent		METHODS AND SYSTEMS FOR ALIGNING REPETITIVE DNA ELEMENTS		Oct 17, 2018
AU	A1	AU2019280010	Dec 11, 2019	Patent	Application
Type : Patent Sub-Type : Application
OPEN TO PUBLIC INSPECTION		Methods And Systems For Aligning Repetitive DNA Elements		Jan 16, 2020

• 15 United States
• 10 France
• 8 Japan
• 7 China
• 5 Korea
• 2 Other

Patent Owner(s)

Patent Owner	Address
ILLUMINA INC	5200 ILLUMINA WAY SAN DIEGO CA 92122

International Classification(s)

• G06F:ELECTRIC DIGITAL DATA PROCESSING

• 2013 Application Filing Year
• G06F Class
• 48303 Applications Filed
• 43929 Patents Issued To-Date
• 90.95 % Issued To-Date

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
BRUAND, Jocelyne	San Diego, US	12	129
# of filed Patents : 12 Total Citations : 129
MANN, Tobias	Ann Arbor, US	28	365
# of filed Patents : 28 Total Citations : 365
RICHARDSON, Tom	San Diego, US	81	4080
# of filed Patents : 81 Total Citations : 4080

Cited Art Landscape

Load Citation

• No Cited Art to Display

Loading Cited Art Landscape...

Patent Citation Ranking

• 19 Citation Count
• G06F Class

• 65.80 % this patent is cited more than
• 9 Age

Forward Cite Landscape

Load Citation

• No Forward Cites to Display

Loading Forward Cite Landscape...

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date
11.5 Year Payment	$7400.00	$3700.00	$1850.00	Oct 21, 2027

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge - 11.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00

Full Text

US Patent Application No: 2017/0044,107

Inhibitors of JMJD2C as Anticancer Agents

---

Abstract

---

The present disclosure provides compounds, pharmaceutical compositions and related methods for the treatment of cancer, e.g., castration-resistant prostate cancer (CRPC). Specifically, the present disclosure provides a series of 8-hydroxyquinoline derivatives which show cytotoxic effects on androgen-independent prostate cancer cells.

---

 

---

Description

---

Claims

---

Claims data not available

---

Legal Events

• No Legal Status data available.